Drs. Schweiger and Bernstein Publish First Case Study Of Latisse For Eyebrow Restoration
The January 2012 issue of the Journal of Drugs in Dermatology contains an article, written by Drs. Schweiger and Bernstein, which is the first case study of eyebrow growth from the topical use of bimatoprost.
Latisse (bimatoprost) is a topical medication that is FDA-approved for eyelash growth. Some physicians have used the medication for “off-label” use, such as use with eyelashes and scalp hair. However, until recently, there had not been any published medical literature describing the off-label use.
Posted by Updated 2016-01-20
The innovations Dr. Bernstein has described through his medical publications are now a part of history. In the Millennium Paper of the journal Dermatologic Surgery, a comprehensive history of the field of dermatologic surgery cites Dr. Bernstein as being one of the three physicians who played a leading role in hair transplantation in the 1980′s and 1990′s.
